| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 06/02/2004 | CN1152013C Hydrate of levo amlodipine salt and preparation thereof |
| 06/01/2004 | US6743941 Process for the production of piperidine derivatives |
| 06/01/2004 | US6743939 Phenylheteroalkylamine derivatives |
| 06/01/2004 | US6743921 Process for the preparation of nonracemic syn-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenyl-piperidin-1-yl)-1-propanol compounds |
| 06/01/2004 | US6743808 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) tetrahydropyridines or piperazines |
| 06/01/2004 | US6743790 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use |
| 06/01/2004 | US6743787 For therapy of metabolic disorders mediated by insulin resistance or hyperglycemia in a mammal |
| 06/01/2004 | US6743373 Reagent based on enantiopure amino acid in which amino group carries activating group to form active precursor of isocyanate group and carboxyl group is substituted; separation of enantiomers having free functional group |
| 06/01/2004 | US6743262 Perfluoroalkyl haloalkyl ethers and compositions and applications thereof |
| 05/27/2004 | WO2004044000A2 Compounds and methods for modulating functions of classical cadherins |
| 05/27/2004 | WO2004043975A1 Palladium complexes with heterocyclic ligands |
| 05/27/2004 | WO2004043952A1 Novel 2,3-dihydro-4(1h)-pyridinone derivatives, method for production thereof and pharmaceutical composition comprising the same |
| 05/27/2004 | WO2004043951A1 Pyrazole derivatives as modulators of peroxisome proliferator activated receptors |
| 05/27/2004 | WO2004043943A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/27/2004 | WO2004043940A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/27/2004 | WO2004043924A1 2-pyridone derivatives as inhibitors of neutrophile elastase |
| 05/27/2004 | WO2004043923A1 Process for making risperidone and intermediates therefor |
| 05/27/2004 | WO2004043922A1 Method of preparation of terfenadine and its derivatives |
| 05/27/2004 | WO2004043921A1 Novel process for the preparation of 4-aryl-3-hydroxymethyl-1-methylpiperidines. |
| 05/27/2004 | WO2004043916A1 Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 05/27/2004 | WO2004043913A2 Hetero-substituted benzimidazole compounds and antiviral uses thereof |
| 05/27/2004 | WO2004043380A2 Small technetium-99m and rhenium labeled agents and methods for imaging tissues, organs and tumors |
| 05/27/2004 | WO2004043379A2 Chemical compounds |
| 05/27/2004 | WO2004043369A2 Sulfonamides |
| 05/27/2004 | WO2004026816A8 Aromatic liver x-receptor modulators |
| 05/27/2004 | WO2003104197A9 Polymorphic form xvi of fexofenadine hydrochloride |
| 05/27/2004 | WO2003088908A3 Heterocyclo inhibitors of potassium channel function |
| 05/27/2004 | WO2002080857A8 Polymorphs of fexofenadine hydrochloride |
| 05/27/2004 | WO2002065977A8 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof |
| 05/27/2004 | US20040102627 Reacting 1-alkoxycarbonyl-3-oxo piperidine compound with an amine; reducing with reducing agent |
| 05/27/2004 | US20040102609 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 05/27/2004 | US20040102490 Antilipemic agents, antidiabetic agents and treatment of obesity |
| 05/27/2004 | US20040102488 Antiinflamamtory agents; autoimmune diseases; antiarthritic agents; anticancer agents; Alzheimer's disease |
| 05/27/2004 | US20040102487 N-substituted tetrahydropyridines and their use as pesticides |
| 05/27/2004 | US20040102482 Antibacterial Mutilins |
| 05/27/2004 | US20040102477 Polymorphic forms of (S)-Repaglinide and the processes for preparation thereof |
| 05/27/2004 | US20040102474 Dietetics; antidiabetic agents; eating disorders |
| 05/27/2004 | US20040102432 Asthma, rhinitis therapy |
| 05/27/2004 | US20040102431 Protease inhibitors |
| 05/27/2004 | US20040099603 Method for separating a phase transfer catalyst by means of a membrane |
| 05/27/2004 | DE10252275A1 Perfluoralkylaniline Perfluoralkylaniline |
| 05/27/2004 | CA2505529A1 Small technetium-99m and rhenium labeled agents and methods for imaging tissues, organs and tumors |
| 05/27/2004 | CA2505098A1 Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 05/27/2004 | CA2504768A1 Compounds and methods for modulating functions of classical cadherins |
| 05/27/2004 | CA2504766A1 2-pyridone derivatives as inhibitors of neutrophile elastase |
| 05/27/2004 | CA2504737A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/27/2004 | CA2503993A1 Novel 2,3-dihydro-4(1h)-pyridinone derivatives, method for production thereof and pharmaceutical composition comprising the same |
| 05/26/2004 | EP1422219A1 Cyclic amine compound |
| 05/26/2004 | EP1421070A1 New piperidinyl derivates as modulators of chemokine receptor activity |
| 05/26/2004 | EP1421063A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
| 05/26/2004 | EP1421062A1 Novel cyclohexyl sulphones |
| 05/26/2004 | EP1420791A1 Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma |
| 05/26/2004 | EP1420788A1 Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders |
| 05/26/2004 | EP1420785A2 SUBSTITUTED INDENO 1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF |
| 05/26/2004 | EP1420775A1 Platinum complexes and their use in cancer treatment |
| 05/26/2004 | EP1420644A1 Substituted propargylamines |
| 05/26/2004 | EP1206446B1 Carboxylic acid amides, their production and their use as drugs |
| 05/26/2004 | EP1027332B1 Novel lactam metalloprotease inhibitors |
| 05/26/2004 | EP1015433B1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments |
| 05/26/2004 | EP1005445B1 N-alkanoylphenylalanine derivatives |
| 05/26/2004 | CN1500086A Aminopiperidine derivatives |
| 05/26/2004 | CN1500085A Lipid lowering biphenylcarboxamides |
| 05/26/2004 | CN1500082A Cyano-5ubstituted dihydropyrimidine compounds and their use to treat diseases |
| 05/26/2004 | CN1151131C Piperidine derivatives useful as CCR5 antagonists |
| 05/26/2004 | CN1151130C Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkane alcohol |
| 05/25/2004 | US6740780 Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines |
| 05/25/2004 | US6740694 Materials handling; fluid flow |
| 05/25/2004 | US6740682 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
| 05/21/2004 | WO2004042351A2 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2004041807A1 Novel compounds |
| 05/21/2004 | WO2004041784A1 Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | WO2004041777A2 Heteroarylpiperidine modulators of chemokine receptor activity |
| 05/21/2004 | WO2004041776A2 SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS |
| 05/21/2004 | WO2004041282A1 Receptor regulator |
| 05/21/2004 | WO2004041279A1 Gamma-aminoamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2004041163A2 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2004041161A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2003084929A8 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa |
| 05/21/2004 | CA2504805A1 Receptor regulator |
| 05/21/2004 | CA2503844A1 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| 05/21/2004 | CA2503720A1 Gamma-aminoamide modulators of chemokine receptor activity |
| 05/21/2004 | CA2503713A1 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 05/21/2004 | CA2502178A1 Heteroarylpiperidine modulators of chemokine receptor activity |
| 05/21/2004 | CA2502174A1 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 05/20/2004 | US20040097731 Hallogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1and tnf |
| 05/20/2004 | US20040097551 As inhibitors of glucosylceramide synthase; for therapy and prophylaxis |
| 05/20/2004 | US20040097550 For therapy of thrombosis, myocardial infarction, arteriosclerosis, inflammation, apoplexia, angina pectoris, restenosis after angioplasty, claudicatio intermittens, tumours, tumour diseases and/or tumour metastases |
| 05/20/2004 | US20040097548 For prophylaxis and therapy of from inflammation, allergic disease, pain, migraine headache, neuralgia, itching, cough, central nervous system disease, digestive organs disease, nausea, emesis, urination disorder, circulatory disease |
| 05/20/2004 | US20040097546 For therapy of obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction |
| 05/20/2004 | US20040097523 Process for making risperidone and intermediates therefor |
| 05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |
| 05/19/2004 | EP1419773A2 4-Phenylpiperidine derivatives as modulators of dopamine neurotransmission |
| 05/19/2004 | EP1418913A1 Substituted urea neuropeptide y y5 receptor antagonists |
| 05/19/2004 | EP1147084B1 Phenylsulphonyl derivatives as 5-ht receptor ligands |
| 05/19/2004 | EP1034164B1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 05/19/2004 | EP1027342B1 Cyclopentene derivatives useful as antagonists of the motilin receptor |
| 05/19/2004 | EP0717736B1 Phosphorus derivatives to treat aids |
| 05/19/2004 | DE10250743A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 05/19/2004 | CN1498210A MCH antagonists and their use in treatment of obesity |
| 05/19/2004 | CN1498206A Biurethane derivatives |